Let’s be honest – there is a disconnect in ibogaine research. On one side, we have promising clinical studies showing ibogaine’s potential for treating opioid use disorder, PTSD, and traumatic brain injury. On the other, we have approximately 10,000 people who have actually undergone ibogaine treatment, many traveling internationally to access it. Their experiences hold invaluable insights that traditional clinical trials might miss.

As someone who has published extensively on ibogaine’s clinical applications (Alan), ...